Page last updated: 2024-08-24

3-iodobenzylguanidine and von Hippel-Lindau Disease

3-iodobenzylguanidine has been researched along with von Hippel-Lindau Disease in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boju, SL; Guptha, R; Kalawat, TC; Kumar, AV; Mogili, HK; R, R; V, SK1
Carrasquillo, JA; Chen, CC; Eisenhofer, G; Kaji, P; Lai, EW; Linehan, WM; Pacak, K; Pinto, PA1
Alexakis, N; Neoptolemos, JP1
Bringer, J; Faurous, P; Jaffiol, C; Pujol, P1
Hayakawa, N; Kataoka, H; Makino, H; Nakagawa, M; Ogura, T; Oishi, T; Otsuka, F1
Chao, DL; Chen, MY; Chew, EY; Oldfield, EH; Reynolds, JC1

Reviews

1 review(s) available for 3-iodobenzylguanidine and von Hippel-Lindau Disease

ArticleYear
Pancreatic neuroendocrine tumours.
    Best practice & research. Clinical gastroenterology, 2008, Volume: 22, Issue:1

    Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Hormones; Humans; Liver Neoplasms; Neoplasm Staging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Receptors, Somatostatin; Somatostatin; Tomography, X-Ray Computed; von Hippel-Lindau Disease

2008

Other Studies

5 other study(ies) available for 3-iodobenzylguanidine and von Hippel-Lindau Disease

ArticleYear
Pheochromocytoma of Urinary Bladder in a Dialysis PatientPheochromocytoma of Urinary Bladder.
    Nephrology (Carlton, Vic.), 2017, Volume: 22, Issue:2

    Topics: 3-Iodobenzylguanidine; Adult; Antihypertensive Agents; Biopsy; Blood Pressure; Carcinoma, Renal Cell; Cystectomy; Drug Therapy, Combination; Humans; Hypertension; Iodine Radioisotopes; Kidney Neoplasms; Male; Nephrectomy; Pheochromocytoma; Radiopharmaceuticals; Renal Dialysis; Treatment Outcome; Urinary Bladder Neoplasms; von Hippel-Lindau Disease

2017
The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome.
    European journal of endocrinology, 2007, Volume: 156, Issue:4

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dopamine; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; von Hippel-Lindau Disease

2007
Metastatic phaeochromocytoma with a long-term response after iodine-131 metaiodobenzylguanidine therapy.
    European journal of nuclear medicine, 1995, Volume: 22, Issue:4

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Bone Neoplasms; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Lung Neoplasms; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Time Factors; von Hippel-Lindau Disease

1995
Normotensive bilateral pheochromocytoma with Lindau disease: case report.
    Endocrine journal, 1996, Volume: 43, Issue:6

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Blood Pressure; Catecholamines; Cerebellar Neoplasms; Hemangioblastoma; Humans; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Tomography, X-Ray Computed; von Hippel-Lindau Disease

1996
Metastatic brainstem pheochromocytoma in a patient with von Hippel-Lindau disease. Case illustration.
    Journal of neurosurgery, 2001, Volume: 94, Issue:1

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Brain Neoplasms; Brain Stem; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; von Hippel-Lindau Disease

2001